期刊文献+

糖脂代谢紊乱对桡骨骨折老年患者骨质疏松的影响 被引量:2

下载PDF
导出
摘要 目的 :观察血糖、血脂水平紊乱对桡骨骨折老年患者罹患骨质疏松的影响。方法 :桡骨骨折老年患者60例均使用定量超声骨密度仪检测桡骨部位的骨密度值,根据是否罹患骨质疏松症分为观察组34例与对照组26例。每组患者均检测空腹血糖(FBG)和血脂水平[甘油三酯(TG)、胆固醇(TC)、高密度脂蛋白(HDL-C)和低密度脂蛋白(LDL-C)]。将FBG、TG、TC等水平与BMD值进行直线相关分析。并使用ROC曲线对桡骨骨折老年患者罹患骨质疏松进行诊断性分析。结果:观察组患者空腹血糖(6.23±1.45mmol/L)、血脂水平:TC(5.98±2.10mmol/L)、TG(1.79±0.99mmol/L)、LDL-C(3.24±0.75mmol/L)、HDL-C(1.35±0.40mmol/L)均显著高于对照组(P均<0.05),而骨密度值(94.52±12.43mg/cm^2)明显低于对照组(P<0.05);通过直线相关可见,观察组患者血糖、血脂水平与其骨密度值均呈负相关(r=-0.945、-0.974、-0.963,P均<0.01)。ROC曲线诊断提示:血糖、血脂水平与桡骨骨折老年患者骨密度关系密切。结论:糖脂代谢紊乱是桡骨骨折老年患者罹患骨质疏松的重要原因。FBG、TG、TC水平是预测桡骨骨折老年患者骨质疏松的有效指标。
作者 陶永清
出处 《交通医学》 2017年第6期563-564,567,共3页 Medical Journal of Communications
  • 相关文献

参考文献1

二级参考文献15

  • 1Cacek AJ. Review of alterations in oral phenytoin bioavailability associated with formulation, antacids and foos. Ther Drug Monit,1986, 8: 166-171.
  • 2Degen PH, Flech G, Cardot JM, et al. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers. Biopharm Drug Dispos, 1994, 15: 519-526.
  • 3Doose DR, Walker SA, Gisclon LG. Single - dose pharmacokinetic of food on the bioavailabilability of topiramate, a novel antiepileptic drug.J Clin Pharmacol, 1996, 36: 884-891.
  • 4Perucca E, Richens A. General principles: biotransformation . In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptie drags. 4thed. New York: Raven Press, 1995, 31-50.
  • 5Anderon GD. A mechanistic approach to antiepileptie drug interactions. Ann Pharmacother, 1998, 32: 554-563.
  • 6Schater SC, Oxcarbazepine: current status and clinical aplications. Exp Opin Invest Drugs, 1999, 8:1103 - 1112.
  • 7Baruzzi A, Albani F, Riva R, et al. Oxcarbazepine: phannacokinetic interaction and their clinical relevance. Epilepsia, 1993, 35: S14- 19.
  • 8May TW, Rambeck B, Jurgens U. Influence of oxcarbazepine and methsuximide on lamotrigine concentration in epileptic patients with and without valproic acid comedication: results of a retro spective study. Ther Drug Monit, 1999, 21:1751-81.
  • 9Anderson GD, Yau MK, Gidai BE, et el. Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clin Pharmacol Ther 1996;60:145 -56.
  • 10Kerrick JM, Wolff DL, Graves NM. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparisnn of two prediction methods. Ann Pharmacother 1995 ;29:470 - 4.

共引文献8

同被引文献17

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部